These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8736934)

  • 1. Modulation of pre-mRNA splicing in the Duchenne muscular dystrophy gene.
    Dunckley MG; Eperon IC; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):276S. PubMed ID: 8736934
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
    Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
    J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenotransplantation of embryonic precursors of human myogenesis for the correction of dystrophinopathy in mice with hereditary muscular dystrophy.
    Yarygin VN; Sukhikh GT; Sitnikov VF; Stenina MA; Kuznetsov AB; Poltavtseva RA; Krivov LI; Voevodin DA; Savchuk VI; Revishchin AV; Korochkin LI; Aleksandrova MA
    Bull Exp Biol Med; 2003 Jul; 136(1):88-92. PubMed ID: 14534620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An explanation for the constitutive exon 9 cassette splicing of the DMD gene.
    Reiss J; Rininsland F
    Hum Mol Genet; 1994 Feb; 3(2):295-8. PubMed ID: 8004097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy.
    Hagiwara Y; Nishio H; Kitoh Y; Takeshima Y; Narita N; Wada H; Yokoyama M; Nakamura H; Matsuo M
    Am J Hum Genet; 1994 Jan; 54(1):53-61. PubMed ID: 8279470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform.
    Rafael JA; Sunada Y; Cole NM; Campbell KP; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1994 Oct; 3(10):1725-33. PubMed ID: 7849695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human dystrophin gene transfer: genetic correction of dystrophin deficiency.
    Dickson G; Dunckley M
    Mol Cell Biol Hum Dis Ser; 1993; 3():283-302. PubMed ID: 8111543
    [No Abstract]   [Full Text] [Related]  

  • 9. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
    Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse.
    Buvoli M; Buvoli A; Leinwand LA
    PLoS One; 2007 May; 2(5):e427. PubMed ID: 17487273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral vectors for gene transfer of full-length human dystrophin cDNAs.
    Murphy S; Turner G; Piper T; Roberts B; Wadworth S; Smith AE; Wells DJ; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):277S. PubMed ID: 8736935
    [No Abstract]   [Full Text] [Related]  

  • 13. Duchenne muscular dystrophy: the gene and the protein.
    Love DR; Davies KE
    Mol Biol Med; 1989 Feb; 6(1):7-17. PubMed ID: 2666821
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene.
    Rapaport D; Lederfein D; den Dunnen JT; Grootscholten PM; Van Ommen GJ; Fuchs O; Nudel U; Yaffe D
    Differentiation; 1992 Apr; 49(3):187-93. PubMed ID: 1377655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newly recognized exons induced by a splicing abnormality from an intronic mutation of the dystrophin gene resulting in Duchenne muscular dystrophy. Mutations in brief no. 213. Online.
    Ikezawa M; Nishino I; Goto Y; Miike T; Nonaka I
    Hum Mutat; 1999; 13(2):170. PubMed ID: 10094556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical diagnosis of Duchenne muscular dystrophy using anti-dystrophin antibodies].
    Arahata K
    No To Shinkei; 1991 May; 43(5):411-9. PubMed ID: 1910928
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of X-chromosome inactivation as a key determinant of the clinicopathologic phenotype of Duchenne muscular dystrophy carriers.
    Matthews PM; Karpati G
    Neurology; 1996 Apr; 46(4):1189-91. PubMed ID: 8780133
    [No Abstract]   [Full Text] [Related]  

  • 20. PCR analysis of muscular dystrophy in mdx mice.
    Chamberlain JS; Phelps SF; Cox GA; Maichele AJ; Greenwood AD
    Mol Cell Biol Hum Dis Ser; 1993; 3():167-89. PubMed ID: 8111539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.